DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
21 jan 2014 - 07:15
Statutaire naam
DSM B.V.
Titel
DSM reports preliminary 2013 results, provides 2014 outlook
Bericht
• 2013 FY EBITDA substantially up to about €1,314 million (2012 FY: €1,109 million)
• Q4 2013 EBITDA of around €316 million (Q4 2012: €243 million)
• Nutrition Q4 EBITDA of approximately €207 million (2012: €204 million)
• Materials Sciences Q4 EBITDA of about €108 million (2012: €66 million)
• Target for 2014 to improve its business performance to at least offset negative currency impact
Royal DSM, the Life Sciences and Materials Sciences company, today reported preliminary, unaudited, results for 2013 and provided an outlook for 2014. Final audited results, in conjunction with its Integrated Annual Report, will be published as scheduled on 26 February 2014.
Gerelateerde downloads
Datum laatste update: 01 september 2024